GI-Reasons- A Trial Of GI Safety Of Celecoxib Compared With Non-Selective Nonsteroidal Antiinflammatory Drugs (NSAIDS)

NCT00373685 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

8067

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis

Interventions

DRUG: Celecoxib
DRUG: Any commercially available NSAID with the indication for osteoarthritis

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.